159 related articles for article (PubMed ID: 23772664)
21. How I treat childhood CML.
Andolina JR; Neudorf SM; Corey SJ
Blood; 2012 Feb; 119(8):1821-30. PubMed ID: 22210880
[TBL] [Abstract][Full Text] [Related]
22. Ring Chromosome 10 in a Case of Acute Promyelocytic Leukemia.
Shehzad S; Nadeem M; Shan S; Shamsi TS
J Coll Physicians Surg Pak; 2016 Nov; 26(11):941-942. PubMed ID: 27981936
[No Abstract] [Full Text] [Related]
23. Long-term molecular remission in promyelocytic transformation of myeloproliferative disease.
Mollee PN; Taylor KM; Williams B; Taylor D; Rodwell R
Leukemia; 1999 Apr; 13(4):648-50. PubMed ID: 10214878
[No Abstract] [Full Text] [Related]
24. [Arsenic treatment for leukemia: new model of human cancer target treatment].
Zhao WW; Chen SJ
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):439-40. PubMed ID: 15854545
[No Abstract] [Full Text] [Related]
25. A case of childhood T cell acute lymphoblastic leukemia with a complex t(9;9) and homozygous deletion of CDKN2A gene associated with a Philadelphia-positive minor subclone.
Ney-Garcia DR; Vieira TP; Liehr T; Bhatt S; de Souza MT; de Figueiredo AF; Ribeiro RC; Silva ML
Blood Cells Mol Dis; 2013 Feb; 50(2):131-3. PubMed ID: 23044159
[No Abstract] [Full Text] [Related]
26. Acute promyelocytic leukemia with complex translocation t(5;17;15)(q35;q21;q22): case report and review of the literature.
Cho SR; Park SJ; Kim HJ; Park IJ; Choi JR; Jung HJ; Park JE
J Pediatr Hematol Oncol; 2011 Oct; 33(7):e326-9. PubMed ID: 21617563
[TBL] [Abstract][Full Text] [Related]
27. Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
Bao L; Lu X; Lai Y; Zhang X; Zhu H; Liu Y; Qin Y; Huang XJ
Leuk Res; 2009 Jul; 33(7):e64-8. PubMed ID: 19297021
[No Abstract] [Full Text] [Related]
28. All-trans retinoic acid and arsenic rescue patients with acute promyelocytic leukemia from a potential 'perfect storm'.
Tallman MS
Leuk Lymphoma; 2010 May; 51(5):745-6. PubMed ID: 20423285
[No Abstract] [Full Text] [Related]
29. Emergence of chronic myelogenous leukemia in a patient with primary thrombocythemia and absence of BCR/ABL rearrangement.
Cesar JM; Cabello P; Ferro T; Navarro JL
Cancer Genet Cytogenet; 2006 May; 167(1):74-7. PubMed ID: 16682291
[TBL] [Abstract][Full Text] [Related]
30. Application of fluorescence in situ hybridization to detect residual leukemic cells with 9;22 and 15;17 translocations.
Tanaka K; Arif M; Eguchi M; Kumaravel TS; Ueda R; Ohno R; Iwato K; Kyo T; Dohy H; Kamada N
Leukemia; 1997 Mar; 11(3):436-40. PubMed ID: 9067586
[TBL] [Abstract][Full Text] [Related]
31. Current treatment of acute promyelocytic leukemia.
Lo Coco F; Ammatuna E; Sanz MA
Haematologica; 2007 Mar; 92(3):289-91. PubMed ID: 17339175
[No Abstract] [Full Text] [Related]
32. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1).
Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M
Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477
[TBL] [Abstract][Full Text] [Related]
33. Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia.
Au WY; Kumana CR; Kou M; Mak R; Chan GC; Lam CW; Kwong YL
Blood; 2003 Jul; 102(1):407-8. PubMed ID: 12814916
[No Abstract] [Full Text] [Related]
34. Treatment of therapy related acute promyelocytic leukemia with the combination of all trans retinoic acid and arsenic trioxide without chemotherapy: a series of three patients.
Malhotra P; Varma N; Arora N; Das R; Nath A; Patel FD; Varma S
Leuk Lymphoma; 2010 May; 51(5):933-6. PubMed ID: 20350274
[No Abstract] [Full Text] [Related]
35. Arsenic trioxide combination improves survival in APL.
Mayor S
Lancet Oncol; 2013 Aug; 14(9):e346. PubMed ID: 24058969
[No Abstract] [Full Text] [Related]
36. CNS relapse in acute promyeloctyic leukemia.
Housman E; Chang P; Lane SW; Blinder R; Galinsky I; Kesari S; Ho VT; Stone RM; Mullally A
J Clin Oncol; 2010 Aug; 28(24):e409-11. PubMed ID: 20530270
[No Abstract] [Full Text] [Related]
37. Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.
Leu L; Mohassel L
Am J Health Syst Pharm; 2009 Nov; 66(21):1913-8. PubMed ID: 19850784
[TBL] [Abstract][Full Text] [Related]
38. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
Chen SJ; Chen LJ; Zhou GB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
[TBL] [Abstract][Full Text] [Related]
39. Sustained molecular remission in advanced acute promyelocytic leukemia with combined pulsed retinoic acid and arsenic trioxide. Clinical evidence of synergistic effect and real-time quantification of minimal residual disease.
Visani G; Piccaluga PP; Martinelli G; Rossi M; Malagola M; Baccarani M
Haematologica; 2003 Apr; 88(4):ELT15. PubMed ID: 12681992
[No Abstract] [Full Text] [Related]
40. A variant form of myelodysplastic syndrome with Ph- minor-BCR/ABL transcript.
Wakayama T; Maniwa Y; Ago H; Kakazu N; Abe T
Int J Hematol; 2001 Jul; 74(1):58-63. PubMed ID: 11530806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
